DBALX
Price
$13.18
Change
-$0.00 (-0.00%)
Updated
May 23 closing price
Net Assets
246.89M
RLBEX
Price
$34.79
Change
-$0.05 (-0.14%)
Updated
May 23 closing price
Net Assets
237.45B
Interact to see
Advertisement

DBALX vs RLBEX

Header iconDBALX vs RLBEX Comparison
Open Charts DBALX vs RLBEXBanner chart's image
Davenport Balanced Income
Price$13.18
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets246.89M
American Funds American Balanced R4
Price$34.79
Change-$0.05 (-0.14%)
VolumeN/A
Net Assets237.45B
DBALX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DBALX vs. RLBEX commentary
May 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBALX is a Buy and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 237B vs. DBALX (247M). DBALX pays higher dividends than RLBEX: DBALX (2.55) vs RLBEX (1.98). DBALX was incepted earlier than RLBEX: DBALX (9 years) vs RLBEX (23 years). DBALX (0.93) is less costly to investors than RLBEX (0.59). DBALX (45.00) and RLBEX (44.00) have comparable annual turnover. RLBEX has a lower initial minimum investment than DBALX: RLBEX (250) vs DBALX (5000). DBALX (5.41) and RLBEX (5.22) have marching annual gain over last year. DBALX (38.24) and RLBEX (37.84) have equivalent 5 years return.
DBALXRLBEXDBALX / RLBEX
Total Expense Ratio0.930.59158%
Annual Report Gross Expense Ratio0.930.59158%
Fund Existence9 years23 years-
Gain YTD2.2681.830124%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets247M237B0%
Annual Yield % from dividends2.551.98129%
Returns for 1 year5.415.22104%
Returns for 3 years9.0722.1941%
Returns for 5 years38.2437.84101%
Returns for 10 yearsN/A54.88-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVO4.730.70
+17.37%
Evotec SE
TELA1.440.05
+3.60%
TELA Bio
TRIN14.470.08
+0.56%
Trinity Capital
BAP204.24-0.18
-0.09%
Credicorp Ltd
INDP0.37-0.01
-2.89%
Indaptus Therapeutics